The present study, based on our information, is the first to investigate the relationship between serum biomarkers VCAM-1 and ICAM-1, EFT, and the CVR predicted by SCORE-2 and SCORE-2OP risk tools in patients with obstructive sleep apnea. This evidence concerns the gene ICAM1 and obstructive sleep apnea syndrome.